Pt BD SHARMA,PGIMS/UHS Trials

Pt BD SHARMA,PGIMS/UHS	Welcome, Profile Billing Logout

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Saikia, Tapan

NCT04641481: An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers

Active, not recruiting

25800

RoW

BBV152, Placebo

Bharat Biotech International Limited, Indian Council of Medical Research, Iqvia Pty Ltd

Covid19, SARS-CoV Infection

01/21

12/22

Kanungo, Suman

NCT04641481: An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers

Active, not recruiting

25800

RoW

BBV152, Placebo

Bharat Biotech International Limited, Indian Council of Medical Research, Iqvia Pty Ltd

Covid19, SARS-CoV Infection

01/21

12/22

Talukdar, Anjan J

NCT04641481: An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers

Active, not recruiting

25800

RoW

BBV152, Placebo

Bharat Biotech International Limited, Indian Council of Medical Research, Iqvia Pty Ltd

Covid19, SARS-CoV Infection

01/21

12/22

Verma, Savita

NCT04641481: An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers

Active, not recruiting

25800

RoW

BBV152, Placebo

Bharat Biotech International Limited, Indian Council of Medical Research, Iqvia Pty Ltd

Covid19, SARS-CoV Infection

01/21

12/22

Hillchol131, NCT05732766: To Evaluate Safety of Oral Cholera Vaccine Hillchol® (BBV131)

Recruiting

1800

RoW

Hillchol vaccine

Bharat Biotech International Limited

Cholera

03/23

08/23

Rai, Sanjay Kumar

NCT04641481: An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers

Active, not recruiting

25800

RoW

BBV152, Placebo

Bharat Biotech International Limited, Indian Council of Medical Research, Iqvia Pty Ltd

Covid19, SARS-CoV Infection

01/21

12/22

MTBVACph2, NCT06997367: Safety and Immunogenicity of a Mycobacterium Tuberculosis Vaccine MTBVAC in Healthy Indian Adults and Adolescents (BBV169/2024)

Recruiting

164

RoW

MTBVAC, BBV169, BCG Sii

Bharat Biotech International Limited

Tuberculosis (TB)

04/26

06/26

Reddy, Prabhakar

NCT04641481: An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers

Active, not recruiting

25800

RoW

BBV152, Placebo

Bharat Biotech International Limited, Indian Council of Medical Research, Iqvia Pty Ltd

Covid19, SARS-CoV Infection

01/21

12/22

Redkar, Sagar Vivek

NCT04641481: An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers

Active, not recruiting

25800

RoW

BBV152, Placebo

Bharat Biotech International Limited, Indian Council of Medical Research, Iqvia Pty Ltd

Covid19, SARS-CoV Infection

01/21

12/22

Singh, Chadramani

NCT04641481: An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers

Active, not recruiting

25800

RoW

BBV152, Placebo

Bharat Biotech International Limited, Indian Council of Medical Research, Iqvia Pty Ltd

Covid19, SARS-CoV Infection

01/21

12/22

Khan, Azhar Ali

NCT04641481: An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers

Active, not recruiting

25800

RoW

BBV152, Placebo

Bharat Biotech International Limited, Indian Council of Medical Research, Iqvia Pty Ltd

Covid19, SARS-CoV Infection

01/21

12/22

Pandey, nil Kumar

NCT04641481: An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers

Active, not recruiting

25800

RoW

BBV152, Placebo

Bharat Biotech International Limited, Indian Council of Medical Research, Iqvia Pty Ltd

Covid19, SARS-CoV Infection

01/21

12/22

Dube, Simmi

NCT04641481: An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers

Active, not recruiting

25800

RoW

BBV152, Placebo

Bharat Biotech International Limited, Indian Council of Medical Research, Iqvia Pty Ltd

Covid19, SARS-CoV Infection

01/21

12/22

Meshram, Priti

NCT04641481: An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers

Active, not recruiting

25800

RoW

BBV152, Placebo

Bharat Biotech International Limited, Indian Council of Medical Research, Iqvia Pty Ltd

Covid19, SARS-CoV Infection

01/21

12/22

NCT04533022 / 2020-000822-24: Safety, Efficacy and Pharmacokinetics of C21 in Subjects With IPF

	May 2023 - May 2023 : Safety and efficacy of AIR study in idiopathic pulmonary fibrosis
	Interim data from AIR STUDY for IPF
	Nov 2022 - Nov 2022: Interim data from AIR STUDY for IPF
	Interim data from AIR STUDY for IPF
	Feb 2022 - Feb 2022: Interim data from AIR STUDY for IPF

Completed

Europe, RoW

C21, Buloxibutid, Compound 21

Vicore Pharma AB, Orphan Reach Ltd.

Idiopathic Pulmonary Fibrosis

03/24

Kumari, Laxmi S

NCT04641481: An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers

Active, not recruiting

25800

RoW

BBV152, Placebo

Bharat Biotech International Limited, Indian Council of Medical Research, Iqvia Pty Ltd

Covid19, SARS-CoV Infection

01/21

12/22

Narang, Shiva

NCT04641481: An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers

Active, not recruiting

25800

RoW

BBV152, Placebo

Bharat Biotech International Limited, Indian Council of Medical Research, Iqvia Pty Ltd

Covid19, SARS-CoV Infection

01/21

12/22

MTBVACph2, NCT06997367: Safety and Immunogenicity of a Mycobacterium Tuberculosis Vaccine MTBVAC in Healthy Indian Adults and Adolescents (BBV169/2024)

Recruiting

164

RoW

MTBVAC, BBV169, BCG Sii

Bharat Biotech International Limited

Tuberculosis (TB)

04/26

06/26

Rao, E Venkat

NCT04641481: An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers

Active, not recruiting

25800

RoW

BBV152, Placebo

Bharat Biotech International Limited, Indian Council of Medical Research, Iqvia Pty Ltd

Covid19, SARS-CoV Infection

01/21

12/22

Venugopal, P

NCT04641481: An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers

Active, not recruiting

25800

RoW

BBV152, Placebo

Bharat Biotech International Limited, Indian Council of Medical Research, Iqvia Pty Ltd

Covid19, SARS-CoV Infection

01/21

12/22

Awad, NT

NCT04641481: An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers

Active, not recruiting

25800

RoW

BBV152, Placebo

Bharat Biotech International Limited, Indian Council of Medical Research, Iqvia Pty Ltd

Covid19, SARS-CoV Infection

01/21

12/22

Ranganadin, Pajanivel

NCT04641481: An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers

Active, not recruiting

25800

RoW

BBV152, Placebo

Bharat Biotech International Limited, Indian Council of Medical Research, Iqvia Pty Ltd

Covid19, SARS-CoV Infection

01/21

12/22

Gumashta, Raghavendra

NCT04641481: An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers

Active, not recruiting

25800

RoW

BBV152, Placebo

Bharat Biotech International Limited, Indian Council of Medical Research, Iqvia Pty Ltd

Covid19, SARS-CoV Infection

01/21

12/22

Multani, Manish

NCT04641481: An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers

Active, not recruiting

25800

RoW

BBV152, Placebo

Bharat Biotech International Limited, Indian Council of Medical Research, Iqvia Pty Ltd

Covid19, SARS-CoV Infection

01/21

12/22

Murthy, Meghana

NCT04641481: An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers

Active, not recruiting

25800

RoW

BBV152, Placebo

Bharat Biotech International Limited, Indian Council of Medical Research, Iqvia Pty Ltd

Covid19, SARS-CoV Infection

01/21

12/22

Akshata

NCT04641481: An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers

Active, not recruiting

25800

RoW

BBV152, Placebo

Bharat Biotech International Limited, Indian Council of Medical Research, Iqvia Pty Ltd

Covid19, SARS-CoV Infection

01/21

12/22

Selvavinayagam, T S

NCT04641481: An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers

Active, not recruiting

25800

RoW

BBV152, Placebo

Bharat Biotech International Limited, Indian Council of Medical Research, Iqvia Pty Ltd

Covid19, SARS-CoV Infection

01/21

12/22

Shameem, Mohammad

NCT04641481: An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers

Active, not recruiting

25800

RoW

BBV152, Placebo

Bharat Biotech International Limited, Indian Council of Medical Research, Iqvia Pty Ltd

Covid19, SARS-CoV Infection

01/21

12/22

NCT06614725: A Study in India on the Immune Response and Safety of a Respiratory Syncytial Virus (RSV) Older Adults (OA) Vaccine When Given to Older Adults 60 Years of Age and Above and Adults 50-59 Years of Age at Increased Risk (AIR) of Respiratory Syncytial Virus Lower Respiratory Tract Disease (RSV-LRTD)

Recruiting

750

RoW

RSVPreF3 OA investigational vaccine, Placebo

GlaxoSmithKline

Respiratory Syncytial Virus Infections

05/25

10/25

Bhatt, Parul

NCT04641481: An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers

Active, not recruiting

25800

RoW

BBV152, Placebo

Bharat Biotech International Limited, Indian Council of Medical Research, Iqvia Pty Ltd

Covid19, SARS-CoV Infection

01/21

12/22

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Saikia, Tapan

NCT04641481: An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers

Active, not recruiting

25800

RoW

BBV152, Placebo

Bharat Biotech International Limited, Indian Council of Medical Research, Iqvia Pty Ltd

Covid19, SARS-CoV Infection

01/21

12/22

Kanungo, Suman

NCT04641481: An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers

Active, not recruiting

25800

RoW

BBV152, Placebo

Bharat Biotech International Limited, Indian Council of Medical Research, Iqvia Pty Ltd

Covid19, SARS-CoV Infection

01/21

12/22

Talukdar, Anjan J

NCT04641481: An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers

Active, not recruiting

25800

RoW

BBV152, Placebo

Bharat Biotech International Limited, Indian Council of Medical Research, Iqvia Pty Ltd

Covid19, SARS-CoV Infection

01/21

12/22

Verma, Savita

NCT04641481: An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers

Active, not recruiting

25800

RoW

BBV152, Placebo

Bharat Biotech International Limited, Indian Council of Medical Research, Iqvia Pty Ltd

Covid19, SARS-CoV Infection

01/21

12/22

Hillchol131, NCT05732766: To Evaluate Safety of Oral Cholera Vaccine Hillchol® (BBV131)

Recruiting

1800

RoW

Hillchol vaccine

Bharat Biotech International Limited

Cholera

03/23

08/23

Rai, Sanjay Kumar

NCT04641481: An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers

Active, not recruiting

25800

RoW

BBV152, Placebo

Bharat Biotech International Limited, Indian Council of Medical Research, Iqvia Pty Ltd

Covid19, SARS-CoV Infection

01/21

12/22

MTBVACph2, NCT06997367: Safety and Immunogenicity of a Mycobacterium Tuberculosis Vaccine MTBVAC in Healthy Indian Adults and Adolescents (BBV169/2024)

Recruiting

164

RoW

MTBVAC, BBV169, BCG Sii

Bharat Biotech International Limited

Tuberculosis (TB)

04/26

06/26

Reddy, Prabhakar

NCT04641481: An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers

Active, not recruiting

25800

RoW

BBV152, Placebo

Bharat Biotech International Limited, Indian Council of Medical Research, Iqvia Pty Ltd

Covid19, SARS-CoV Infection

01/21

12/22

Redkar, Sagar Vivek

NCT04641481: An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers

Active, not recruiting

25800

RoW

BBV152, Placebo

Bharat Biotech International Limited, Indian Council of Medical Research, Iqvia Pty Ltd

Covid19, SARS-CoV Infection

01/21

12/22

Singh, Chadramani

NCT04641481: An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers

Active, not recruiting

25800

RoW

BBV152, Placebo

Bharat Biotech International Limited, Indian Council of Medical Research, Iqvia Pty Ltd

Covid19, SARS-CoV Infection

01/21

12/22

Khan, Azhar Ali

NCT04641481: An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers

Active, not recruiting

25800

RoW

BBV152, Placebo

Bharat Biotech International Limited, Indian Council of Medical Research, Iqvia Pty Ltd

Covid19, SARS-CoV Infection

01/21

12/22

Pandey, nil Kumar

NCT04641481: An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers

Active, not recruiting

25800

RoW

BBV152, Placebo

Bharat Biotech International Limited, Indian Council of Medical Research, Iqvia Pty Ltd

Covid19, SARS-CoV Infection

01/21

12/22

Dube, Simmi

NCT04641481: An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers

Active, not recruiting

25800

RoW

BBV152, Placebo

Bharat Biotech International Limited, Indian Council of Medical Research, Iqvia Pty Ltd

Covid19, SARS-CoV Infection

01/21

12/22

Meshram, Priti

NCT04641481: An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers

Active, not recruiting

25800

RoW

BBV152, Placebo

Bharat Biotech International Limited, Indian Council of Medical Research, Iqvia Pty Ltd

Covid19, SARS-CoV Infection

01/21

12/22

NCT04533022 / 2020-000822-24: Safety, Efficacy and Pharmacokinetics of C21 in Subjects With IPF

	May 2023 - May 2023 : Safety and efficacy of AIR study in idiopathic pulmonary fibrosis
	Interim data from AIR STUDY for IPF
	Nov 2022 - Nov 2022: Interim data from AIR STUDY for IPF
	Interim data from AIR STUDY for IPF
	Feb 2022 - Feb 2022: Interim data from AIR STUDY for IPF

Completed

Europe, RoW

C21, Buloxibutid, Compound 21

Vicore Pharma AB, Orphan Reach Ltd.

Idiopathic Pulmonary Fibrosis

03/24

Kumari, Laxmi S

NCT04641481: An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers

Active, not recruiting

25800

RoW

BBV152, Placebo

Bharat Biotech International Limited, Indian Council of Medical Research, Iqvia Pty Ltd

Covid19, SARS-CoV Infection

01/21

12/22

Narang, Shiva

NCT04641481: An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers

Active, not recruiting

25800

RoW

BBV152, Placebo

Bharat Biotech International Limited, Indian Council of Medical Research, Iqvia Pty Ltd

Covid19, SARS-CoV Infection

01/21

12/22

MTBVACph2, NCT06997367: Safety and Immunogenicity of a Mycobacterium Tuberculosis Vaccine MTBVAC in Healthy Indian Adults and Adolescents (BBV169/2024)

Recruiting

164

RoW

MTBVAC, BBV169, BCG Sii

Bharat Biotech International Limited

Tuberculosis (TB)

04/26

06/26

Rao, E Venkat

NCT04641481: An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers

Active, not recruiting

25800

RoW

BBV152, Placebo

Bharat Biotech International Limited, Indian Council of Medical Research, Iqvia Pty Ltd

Covid19, SARS-CoV Infection

01/21

12/22

Venugopal, P

NCT04641481: An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers

Active, not recruiting

25800

RoW

BBV152, Placebo

Bharat Biotech International Limited, Indian Council of Medical Research, Iqvia Pty Ltd

Covid19, SARS-CoV Infection

01/21

12/22

Awad, NT

NCT04641481: An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers

Active, not recruiting

25800

RoW

BBV152, Placebo

Bharat Biotech International Limited, Indian Council of Medical Research, Iqvia Pty Ltd

Covid19, SARS-CoV Infection

01/21

12/22

Ranganadin, Pajanivel

NCT04641481: An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers

Active, not recruiting

25800

RoW

BBV152, Placebo

Bharat Biotech International Limited, Indian Council of Medical Research, Iqvia Pty Ltd

Covid19, SARS-CoV Infection

01/21

12/22

Gumashta, Raghavendra

NCT04641481: An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers

Active, not recruiting

25800

RoW

BBV152, Placebo

Bharat Biotech International Limited, Indian Council of Medical Research, Iqvia Pty Ltd

Covid19, SARS-CoV Infection

01/21

12/22

Multani, Manish

NCT04641481: An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers

Active, not recruiting

25800

RoW

BBV152, Placebo

Bharat Biotech International Limited, Indian Council of Medical Research, Iqvia Pty Ltd

Covid19, SARS-CoV Infection

01/21

12/22

Murthy, Meghana

NCT04641481: An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers

Active, not recruiting

25800

RoW

BBV152, Placebo

Bharat Biotech International Limited, Indian Council of Medical Research, Iqvia Pty Ltd

Covid19, SARS-CoV Infection

01/21

12/22

Akshata

NCT04641481: An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers

Active, not recruiting

25800

RoW

BBV152, Placebo

Bharat Biotech International Limited, Indian Council of Medical Research, Iqvia Pty Ltd

Covid19, SARS-CoV Infection

01/21

12/22

Selvavinayagam, T S

NCT04641481: An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers

Active, not recruiting

25800

RoW

BBV152, Placebo

Bharat Biotech International Limited, Indian Council of Medical Research, Iqvia Pty Ltd

Covid19, SARS-CoV Infection

01/21

12/22

Shameem, Mohammad

NCT04641481: An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers

Active, not recruiting

25800

RoW

BBV152, Placebo

Bharat Biotech International Limited, Indian Council of Medical Research, Iqvia Pty Ltd

Covid19, SARS-CoV Infection

01/21

12/22

Recruiting

750

RoW

RSVPreF3 OA investigational vaccine, Placebo

GlaxoSmithKline

Respiratory Syncytial Virus Infections

05/25

10/25

Bhatt, Parul

NCT04641481: An Efficacy and Safety Clinical Trial of an Investigational COVID-19 Vaccine (BBV152) in Adult Volunteers

Active, not recruiting

25800

RoW

BBV152, Placebo

Bharat Biotech International Limited, Indian Council of Medical Research, Iqvia Pty Ltd

Covid19, SARS-CoV Infection

01/21

12/22



	Diseases Companies Products Productz Mechanisms of Action Sites